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A B S T R A C T
Members of the RNaseA family are present in various tissues and secretions but their function is not well
understood. Some of the RNases are proposed to participate in host defence. RNase4 and RNase5 are present in
cows' milk and have antimicrobial activity. However, their presence in many tissues and secretions has not been
characterised. We hypothesised that these two RNases are present in a range of tissues and secretions where
they could contribute to host defence. We therefore, determined the relative abundance of RNase4 and RNase5
mRNA as well as protein levels in a range of host defence related and other tissues as well as a range of
secretions in cattle, using real time PCR and western blotting. The two RNases were found to be expressed in
liver, lung, pancreas, mammary gland, placenta, endometrium, small intestine, seminal vesicle, salivary gland,
kidney, spleen, lymph node, skin as well as testes. Corresponding proteins were also detected in many of the
above tissues, as well as in seminal ﬂuid, mammary secretions and saliva. This study provides evidence for the
presence of RNase4 and RNase5 in a range of tissues and secretions, as well as some major organs in cattle. The
data are consistent with the idea that these proteins could contribute to host defence in these locations. This
work contributes to growing body of data suggesting that these proteins contribute to the physiology of the
organism in a more complex way than acting merely as digestive enzymes.
1. Introduction
The mammalian ribonuclease (RNase) superfamily comprises eight
canonical RNases of 14–16 kDa, for which orthologues or paralogues
are present in all vertebrates, as well as additional RNases present in
only some mammals. All members of this superfamily are secretory
proteins that share sequence similarity with bovine pancreatic RNaseA
and contain 6–8 cysteine residues that are necessary for forming their
native three dimensional structures. Some, but not all RNases of this
family, have RNase activity, which is associated with a conserved
catalytic motif CKXXNTF [1].
RNases are present in a wide range of tissues and secretions, as well
as some major organs. RNaseA is secreted by the pancreas and has
been suggested to play a role in digestion [2]. RNase5 is secreted by
endothelial cells and has been proposed to play a role in angiogenesis
[3,4]. RNase4 and RNase5 are also present in milk and colostrum [5–
7]. An RNase, named seminal RNase, has also been reported in seminal
ﬂuid [8,9], and RNase3 has been reported to be present in saliva [10].
RNases are also associated with immune cells. For example, RNase2
and RNase3 are present in neutrophils and eosinophils [11–14],
Eosinophil-Associated RNase11 (EAR11) has been detected in macro-
phages [15], and monocytes have been reported to secrete RNase4
[16,17]. Paneth cells present in the intestine of mice have also been
shown to secrete RNase5 [18]. RNases are also expressed in major
internal organs, with RNase6 being reported to be present in kidney
[19], while RNase2, RNase3 and RNase6 all have been reported to be
present in liver [20]. Thus, existing knowledge of RNases expression
presents an incomplete picture of their physiological role.
Several members of the RNaseA family have been reported to have
host defence associated activities [21–24]. Recombinant mouse
RNase5 has been shown to have antimicrobial activity against some a
number of microbial pathogens [18,25], and RNase4 and RNase5 from
cows' milk have been reported to have antimicrobial activity against
Candida albicans [5]. Cows' milk RNase5 (angiogenin-1), angiogenin-
2 and RNase4 have been shown to enhance the antimicrobial activity of
lactoferrin and lactofericin against a range of Gram-negative and
Gram-positive bacteria [26]. The protein sequences of RNase4 and
RNase5 are similar (45% amino acid sequence identity) and possess
key features of the RNase A superfamily such as a secretion leader
sequence, 6–8 cysteine residues for forming the three-dimensional
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structure and the conserved catalytic triad. Both these RNases possess
ribonuclease activity, but the activity of RNase5 is signiﬁcantly less
potent than that of RNase4 [27].
RNase3 has been shown to possess potent bactericidal activity
against Escherichia coli and Staphylococcus aureus [28–30]. In
addition, RNase7 from human skin has been demonstrated to have
antimicrobial activity against Enterococcus facieum and S. aureus
[31,32]. Recently, both RNase6 and RNase7 have been shown to have
antimicrobial activity against a number of uropathogenic bacteria [33].
Moreover, mRNA and protein levels of RNase6 and RNase7 were up-
regulated in the infected urinary tract [33,34]. Besides these antimi-
crobial activities, some RNases have also been shown to possess
antiviral activity. RNase2 and RNase3 are closely related, both
biochemically and functionally [35]. These RNases have been demon-
strated to reduce the infectivity of respiratory syncytial virus and
human immunodeﬁciency virus in cell culture [36,37]. Other activities
have also been reported. For example, RNase3 has been reported to
have antihelminthic activity, with high toxicity demonstrated against
Schistosoma mansoni, Brugia pahangi and Trichinella spiralis [38–
40]. RNase3 has also been reported to have cytotoxic activity against
bronchial epithelial cells [41], and bovine seminal RNase has been
shown to have cytotoxic activity on proliferating lymphocytes [42].
Furthermore, some RNases have been proposed to act as chemoat-
tractants. For example, RNase2 and EAR2 have been demonstrated to
stimulate the migration of immature human dendritic cells [43].
Collectively, these observations suggest that some of the RNases may
contribute to host defence. The means through which they might play
this role have been proposed for some RNases [30,44–47], while for
others, this remains poorly characterised.
Host defence in cattle has several unique features, and resistance to
infection in this species is an economically signiﬁcant trait. Many
aspects of host defence in cattle are incompletely understood, including
the possible involvement of the RNases. Only limited data are available
on expression pattern of RNases in cattle, with RNase4 and RNase5
expression reported only in the mammary gland [5,26]. Therefore, the
purpose of this study was to investigate the abundance of mRNA
transcripts of RNase4 and RNase5 in cattle in a range of tissues, in
order to address whether expression occurs beyond the mammary
gland, and thereby better understand their possible roles in host
defence in this species. The mRNA transcript accumulation of
RNase4 and RNase5 in a range of host-defence related tissues was
assessed by quantitative PCR (qPCR). The protein abundance of these
two RNases was also measured in a range of tissues and secretions
using western blotting. The data show that RNase4 and RNase5 are
most highly expressed in the liver and are present in a wider range of
host-defence related tissues and secretions than has previously been
reported. These ﬁndings support the concept that RNase4 and RNase5
play a role in host defence in cattle.
2. Materials and methods
2.1. Reagents
All the chemicals used in the present study were purchased from
Sigma-Aldrich (St. Louis, MO), unless otherwise stated.
2.2. Tissue and secretion collection
All animal manipulations and tissue collection was performed with
the approval of the Ruakura Animal Ethics committee. All tissues were
collected from New Zealand Holstein-Friesian dairy cattle. Male
reproductive tract tissues were collected after slaughtering a healthy,
3 year old dairy bull. Fresh tissues were snap frozen in liquid nitrogen
(N2) and powdered under liquid N2 using a mortar and pestle and
stored at −80 °C. For the collection of seminal ﬂuid, the ejaculatory
duct was removed from the slaughtered bull and its contents were
removed by squeezing the duct from one end. All other tissues
including pancreas, spleen, endometrium, kidney, salivary gland,
lungs, liver, lymph node, small intestine, skin, mammary gland, brain,
and placenta were collected from a healthy non-pregnant cow during
peak lactation, slaughtered 12 h after the last milking. Liver and
mammary gland tissues were also obtained from this cows as well as
two separate cows. Colostrum, milk and serum was collected from a
separate cow, 6 h after calving. Saliva was obtained from a healthy,
heifer using a hollow steel bit connected to a vacuum pump as
previously described [48].
2.3. Bovine PBMC preparation
Bovine peripheral blood mononuclear cells (PBMCs) were puriﬁed
from fresh bovine blood using a Lymphoprep (Axis-Shield PoC AS,
Oslo, Norway) solution according to a previously described method
[49], with minor modiﬁcations as follows. Peripheral blood was
collected into vacationers (BD, Biosciences) containing the anticoagu-
lant acid citrate dextrose (ACD) via jugular vein puncture of a cow. A
16 mL portion of fresh blood was diluted by mixing it with 17 mL of
calcium and magnesium free Hank’s Balanced Salt Solution (HBSS)
(Invitrogen, New Zealand). This diluted blood was then layered care-
fully onto 12 mL of Lymphoprep (Axis-Shield PoC AS, Oslo, Norway) in
a 50 mL tube. The sample was then centrifuged at 800×g for 40 min at
20 °C, without using the brake, in a swing-bucket rotor. The pale grey
cell layer containing monocytes and lymphocytes was recovered by
aspiration from the Lymphoprep–buﬀer interface. The cells were
diluted in 40 mL of calcium and magnesium free HBSS medium and
centrifuged again at 250×g for 7 min at 4 °C. The supernatant was
discarded and 3 volumes of erythrocyte lysis buﬀer (15 mM NH4Cl,
1 mM KHCO3 and 10 mM EDTA) was added to the residual cell
suspension and incubated for 5 min at room temperature to lyse the
contaminating erythrocytes. The cells were then washed with phos-
phate buﬀered saline (PBS) and re-suspended in 5 mL of RPMI-1640
culture medium. The viability of PBMCs was determined by using a
trypan blue exclusion assay and found to be > 95%.
2.4. RNA isolation and cDNA synthesis
A 100 mg portion of each powdered bovine tissue sample, was
thawed and homogenized in 3 mL of TRIzol reagent (Invitrogen,
Auckland, New Zealand) and total RNA was isolated according to the
manufacturer's instructions. For successful RNA isolation from pan-
creas, the tissue was stored in RNAlater® (Ambion, CA) and RNA was
isolated according to manufacturer's instructions. The quantity of the
puriﬁed RNA was determined using a Nanodrop ND-1000 Analyser
(NanoDrop Technologies, Wilmington, DE, USA). This puriﬁed RNA
was incubated for 1 h at 37 °C in DNase-I (New England Biolab) per
50 µL containing 10 µg RNA to digest genomic DNA. After the
incubation, 1 µL of 0.5 M EDTA (pH 8.0) was added to the mixture,
which was then incubated at 75 °C for 10 min to inactivate the DNase-I
enzyme. The RNA was then precipitated with 3 M Sodium Acetate, pH
5.2 and dissolved in diethylpyrocarbonate- (DEPC) treated water. The
RNA was then quantiﬁed by spectrophotometric analysis using a
Nanodrop ND-1000 Analyser (NanoDrop Technologies, Wilmington,
DE, USA). The 260/280 ratios of the puriﬁed RNA samples were
between 1.9 and 2.0 indicating high purity. The integrity of the RNA
was conﬁrmed by denaturing agarose gel electrophoresis. The RNA was
then reverse transcribed into cDNA using the Super script II First-
Strand Synthesis System (Life technologies, NZ) according to the
manufacturer's instructions. Brieﬂy, 1 µg of DNase-I-treated total
RNA from the tissue was reverse transcribed using Oligo dT (0.5 µg)
as the primer and 50 units of Super script II RT in a total of 20 µL.
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2.5. Messenger RNA transcript analysis of RNase4 and RNase5 by
real-time quantitative PCR
The relative abundance of RNase4 and RNase5 mRNA transcripts
was determined by qPCR using a Corbett Rotorgene 6000 instrument
(Qiagen) with SYBR ExTaq Mix (Takara, Japan) according to a
previously published method [50]. The PCR program comprised an
initial denaturation for 3 min, followed by 40 cycles of 95 °C for 10 s,
and 60 °C for 25 s. All cDNA mixtures were diluted 1/10, and 2 µL of
this diluted cDNA was subjected to qPCR ampliﬁcation in a 20 µL
reaction volume using RNase4 and RNase5 speciﬁc primer pairs as
previously described [51]. The expression levels of the genes were
determined by a previously described method [52]. Brieﬂy, the mRNA
transcript accumulation of RNase4 and RNase5 were quantiﬁed
relative to the geometric mean of three housekeepers namely beta-
tubulin, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and
cyclophilin-A, and normalized for diﬀerent ampliﬁcation eﬃciencies.
All ampliﬁcation eﬃciencies were between 1.6 and 1.8 (data not
shown). Each sample was measured in triplicate. A no template control,
an RT negative control, and a dissociation curve analysis were
performed in each ampliﬁcation. These analyses produced a single
discrete peak for all the primer pairs, showing that the reaction product
contained a single amplicon.
Analyses of mRNA expression of RNase4 and RNase5 was per-
formed on tissues obtained from a number ofcattle. Liver and
mammary gland tissues were collected from three individual cows,
while all other tissues were from a single a bull (for the male-speciﬁc
tissues) and a cow (or all other tissues). The reason for this collection
strategy was to demonstrate that the expression of mRNA transcripts of
RNase4 and RNase5 has very low variability among diﬀerent biological
replicates using liver and mammary tissues, before measuring their
relative abundance in a wider set of tissues from a single animal.
2.6. Preparation of bovine milk RNases
RNase4 and RNase5 were prepared from bovine milk as previously
described (14). Brieﬂy, bulk milk was obtained after skimming and
homogenization at a dairy factory and subjected to three successive
rounds of cation exchange chromatography that were greater than 99%
pure with no detectable contaminating proteins as assessed by SDS gel
electrophoresis. The identity of the RNases was conﬁrmed by matrix-
assisted laser desorption ionisation time of-ﬂight (MALDI-TOF) mass
spectrometry. The RNaseA puriﬁed from bovine pancreas was pur-
chased from Sigma Aldrich (St. Louis, MO) (Catalogue # R6513).
2.7. Western blotting
Powdered frozen tissues (100 mg), as described above from a cow
and a bull, were added to 1 mL of cold Low Salt buﬀer (10 mM HEPES,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 100 mM sodium ortho-
vanadate and 0.2 mM PMSF) containing Complete Protease Inhibitor
Cocktail (Roche, Auckland, New Zealand). This tissue suspension was
sonicated using a Vibracell sonicator (Sonics and Material Inc.,
Danbury, USA) for 3 cycles of 15 s bursts on ice with a 2 min cooling
between each cycle. After the ﬁnal sonication, samples were centrifuged
at 500×g for 10 min at 4 °C to remove cellular debris. The total protein
concentration of the resulting supernatant was determined using the
Bradford protein assay [53]. Each sample was then diluted in sodium
dodecyl sulphate (SDS) sample buﬀer (10% Glycerol, 5% β-mercap-
toethanol, 2% SDS and 62.5 mM Tris, pH 6.8) to obtain a ﬁnal protein
concentration ranging from 5 mg/mL protein. A 105 µg portion of total
protein was subjected to electrophoresis on a 12% SDS-polyacrylamide
gels and then transferred to nitrocellulose membranes (Amersham
Biosciences, UK) by electroblotting. As a positive control, 50 ng of
puriﬁed RNase4 or RNase5 were also included in each gel. The
membrane was blocked with 4% fat-free milk and then probed with a
1/5000 dilution of polyclonal rabbit IgG antibody raised against full
length bovine RNase4 or RNase5 produced using a method and
antibodies as previously described [5]. The membrane was then probed
with horseradish peroxidase (HRP) conjugated anti-rabbit immuno-
globulin G raised in goat (Sigma, St. Louis, MO) at a 1/25,000 dilution.
After washing, the signals were visualized by chemiluminescence as
described previously [54]. The membrane was exposed to a photo-
graphic ﬁlm for up to 3 min before developing using an X-ray
developer.
3. Results
3.1. RNase4 and RNase5 mRNA in bovine tissues
In order to provide evidence for a host defence function for RNase4
and RNase5 in tissues and secretions other than milk, their relative
mRNA transcript abundance was examined in endometrium, isolated
peripheral blood mononuclear cells (PBMCs), small intestine, skin,
lymph node, salivary gland, pancreas, lung, seminal vesicle, testes as
well as the mammary gland. These tissues were chosen because they
are exposed to pathogens or are known to respond to them. Abundance
of RNase4 and RNase5 was also analysed in some major organs; liver,
kidney, spleen, and brain, as these tissues are known to express other
members of the RNase family. Both RNase4 and RNase5 mRNA
transcripts were present in all tissues analysed except brain, although
the abundance diﬀered markedly among the tissues (Fig. 1). RNase4
and RNase5 transcripts were found to be the most abundant in liver,
with other tissues having a far lesser abundance (Fig. 1). Pancreas,
seminal vesicle, small intestine, lung and placenta also contained
substantive amounts of RNase4 and RNase5 mRNA transcripts, similar
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Fig. 1. Tissue wide mRNA transcripts accumulation of RNase4 and RNase5
in cattle. A total of 1 µg of DNase-I-treated RNA from the indicated tissues was reverse
transcribed into cDNA. The resulting cDNA preparation was diluted 1/10 and 2 µL of
that cDNA was subjected to qPCR to analyse the accumulation of the mRNA transcripts
of bovine RNase4 and RNase5. The accumulation of RNase4 and RNase5 mRNA
transcripts is represented relative to the geometric mean of the mRNA transcript
accumulation of three reference genes, i.e. beta-tubulin, GAPDH, and cyclophilin A.
Data in panels A and B show the mean ( ± SE) from analysis of tissue from three
individual cattle, while panels C and D show triplicate analyses of one individual cow.
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to that of mammary tissue. However, salivary gland, endometrium,
skin, kidney, spleen, lymph node, PBMCs, and testes had a relatively
low abundance of RNase4 and RNase5 transcripts. Analysis of liver and
mammary tissue from multiple cattle showed that inter-animal biolo-
gical variation was moderate (maximum SE± 1.7 in liver and 0.93 in
mammary gland) and that the diﬀerences between the two types of
tissue were signiﬁcant (p=0.01 for RNase4 and 0.001 for RNase5).
Overall, these results show that liver rather than the mammary gland is
the predominant site of expression of RNase4 and RNase5 mRNA
transcripts in cattle. Furthermore, the results show that expression is
not limited to these two tissues but also occurs in a range of exocrine
and immune-associated tissues and cells. These results establish that
RNase4 and 5 expression occurs more widely among tissues than has
been previously reported in any species.
3.2. Assessment of cross reactivity of RNase4 and RNase5 polyclonal
antibodies
The speciﬁcity of the polyclonal antibodies raised against full length
bovine RNase4 and RNase5 proteins was determined by western
blotting using highly pure RNase4, RNase5, and RNaseA.
The result conﬁrmed that RNase4 polyclonal antibodies speciﬁcally
detect bovine RNase4 and do not cross-react with either bovine RNase5
with which it shares closest sequence similarity among other members
of the RNase family, or a second member of the family, RNaseA
(Fig. 2). Similarly, the RNase5 polyclonal antibodies detected only
RNase5 and not RNase4 or RNaseA (Fig. 2).
3.3. Abundance of RNase4 and RNase5 protein among bovine tissues
and secretions
The abundance of RNase4 and RNase5 protein among a similar
range of tissues as described above was evaluated by western blotting.
In addition, a range of secretions and body ﬂuids were also assessed.
These analyses aimed to determine if RNase4 and RNase5 mRNA
abundance are correlated with the abundance of their corresponding
proteins within each of these tissues, and whether or not the RNases
are present in a range of biological ﬂuids.
The RNase4 protein was found to be most abundant in pancreas
and seminal vesicle of all the tissues analysed (Fig. 3A). It was also
present at lesser abundance in salivary gland, endometrium, skin as
well as the kidney (Fig. 3A). RNase4 was not detected in the mammary
gland, small intestine, spleen or lymph node. Overall, RNase5 was
found to have a broadly similar pattern of tissue distribution to that of
RNase4 (Fig. 3A). However, some diﬀerences in the pattern of
expression were observed between the two RNases in some tissues.
RNase5 was detected in the small intestine and lymph node, in contrast
to RNase4. Also, the relative abundance of the RNase protein did not
correlate with the relative abundance of its corresponding mRNA in
some tissues, speciﬁcally liver, salivary gland, and mammary gland.
Notably, in liver, only a weak signal was observed for the RNase4 and
RNase5 proteins despite this tissue having the highest abundance of
mRNA transcripts for both the RNases. Similarly, a large diﬀerence was
observed between the levels of RNase4 and RNase5 mRNA and protein
in mammary tissue. These results can be explained if both tissues
secrete almost all of the RNase4 and 5 they produce. However, further
experimentation would be required to prove this unequivocally. The
blots were stained for total protein with Ponceau S to conﬁrm equal
loading (Fig. 3B). Control blots probed with secondary antibody alone
produced no signal, conﬁrming that the signal was due to the primary
antibody (data not shown).
The presence of RNase4 and RNase5 was also examined in a range
of additional secretions and body ﬂuids. Surprisingly, RNase4 and
RNase5 proteins were both most abundant in seminal ﬂuid compared
with the other ﬂuids analysed (Fig. 4A), with the relative abundance in
this secretion being at least twice that in milk. This suggests that
RNase4 and RNase5 may be important proteins of the seminal ﬂuid
and play a role in protecting seminal vesicle and sperm from patho-
gens. Another band of slightly higher molecular weight was also
observed in seminal ﬂuid sample in both the western blots. This could
represent a multimeric form, a complex with another protein or it could
be the result of post-translational modiﬁcation of the protein in this
secretion. Which of these possible explanations is the case has not been
further investigated. Both RNase4 and RNase5 were present in
colostrum at approximately the same abundance as in milk (Fig. 4A).
Only RNase4, and not RNase5, was detected in saliva. Also, neither
RNase4 nor RNase5 was detected in serum. The blot was stained for
total protein with Ponceau S to conﬁrm approximately equal loading
(Fig. 4B). Overall, these ﬁndings show that RNase4 and RNase5
proteins are present in a range of secretions.
4. Discussion
This study has revealed that the RNase4 and RNase5 genes are
most highly expressed in the liver and that their mRNAs and
corresponding proteins are present in a wider range of tissues than
previously reported in studies of human, cattle, and rodents
[5,7,18,26,55–57]. The dynamics of variation of the levels of RNase4
kDa
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Fig. 2. Assessment of cross-reactivity of RNase4 and RNase5 polyclonal antibodies. Cross-reactivity of RNase4 and RNase5 polyclonal antibodies was evaluated by western
blotting. Varying amounts of puriﬁed RNase4, RNase5 and bovine pancreatic RNaseA (as indicated) were subjected to SDS-PAGE and then transferred onto a nitrocellulose membrane.
This was probed with aﬃnity puriﬁed primary anti-RNase4 or anti-RNase5 antibodies and subsequently with HRP conjugated goat anti-rabbit IgG antibody. The signals were visualized
by enhanced chemiluminescence followed by exposure to X-ray ﬁlm for 30 s.
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and RNase5 within populations of cattle is not addressed in this study.
All of the tissues in which these RNases are present have a host defence
function capability, so the ﬁndings are consistent with the idea that
RNase4 and RNase5 play a role in host defence. The relative abundance
of RNase4 and RNase5 mRNA transcripts among tissues appears to
correlate with their corresponding proteins in most of the tissues, but
not in liver, mammary tissue, and salivary gland. One possible
explanation for this is the particularly high secretory capacity of these
tissues leading to a high ﬂux of RNases through the intracellular space
and accumulation in the extracellular space.
The observation made in this study, that high levels of mRNA
transcripts of RNase4 and RNase5 are present in bovine liver, is in
accordance with the previously reported high levels of these RNases in
the livers of both humans and mice [33,55–58]. Since all members of
this family are secreted proteins and their genes contain a secretion
leader sequence, it is likely that these RNases are secreted into the
extracellular space from liver. However, neither RNase was detected in
serum. It is possible that the RNases are present in serum but that their
detection is limited by the dilution eﬀect consequent on the very high
concentration of major serum proteins such as albumin. Further
research is required to conﬁrm the secretion rate and fate of RNase4
and RNase5 in bovine liver.
Previous work has shown that RNase4 and RNase5 puriﬁed from
cows’ milk have antimicrobial activity against the yeast, C. albicans, but
not against the mastitis causing pathogen S. uberis [5]. It is possible,
but not yet demonstrated, that the RNases have anti-fungal properties
in vivo and at least part of their function is to kill fungal pathogens that
have invaded the mammary gland, the oral cavity, the intestinal tract,
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Fig. 3. Abundance of RNase4 and RNase5 protein in the indicated tissues in cattle. (A). Abundance of RNase4 (upper two panels) and RNase5 (lower two panels) in
pancreas, spleen, endometrium, kidney, salivary gland, lungs, liver, lymph node, small intestine, skin, and mammary gland tissues of a cow as evaluated by western blot. A total of 105 µg
of total protein was subjected to SDS-PAGE and then transferred onto a nitrocellulose membrane. This was probed with aﬃnity puriﬁed primary anti-RNase4 or anti-RNase5 antibodies
and subsequently with HRP conjugated goat anti-rabbit IgG antibody. The signals were visualized by enhanced chemiluminescence followed by exposure to X-ray ﬁlm for 3 min (B).
Ponceau S stained images of the membranes is shown to indicate the protein loaded in Fig. 3A.
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Fig. 4. Presence of RNase4 and RNase5 protein in the indicated body ﬂuids in cattle. (A). Presence of RNase4 (upper panel) and RNase5 (lower panel) in saliva, seminal
ﬂuid, milk-1 (uninfected), milk-2 (mastitic), colostrum, and serum in cattle as evaluated by western blotting. A total of 40 μg of protein from various ﬂuids or secretions were subjected to
SDS-PAGE and then transferred to nitrocellulose membrane. This membrane was then probed with anti-RNase4 or anti-RNase5 antibodies followed by probing with HRP conjugated
goat anti-rabbit antibody. The signals were visualized by enhanced chemiluminescence followed by exposure to X-ray ﬁlm for 2 min (B). Ponceau S stained images of the membranes is
shown to indicate the protein loaded in Fig. 4A.
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or the reproductive tract, all of which have access to the external
environment and are likely to be exposed to pathogens. RNase7 from
human skin has been demonstrated to have antimicrobial activity
against a range of cutaneous microbes [25,32,59,60]. In addition,
RNase3, RNase6 and RNase7 have been shown to possess antimicro-
bial activity [29,30,33,34,61]. RNase2, one of the major secretory
proteins of human eosinophils does not possess broad-spectrum
antibacterial activity [61], but it displays antiviral activity against a
range of viruses [37,62,63]. In addition, RNase3 has been shown to
have anti-viral as well as anti-parasitic activities [36,38–40]. Together,
these ﬁndings suggest that antimicrobial activity could be a common
function among several members of the RNaseA superfamily.
Adding further weight to a host defence role of the RNases, some of
the RNases are induced upon infection in host defence related tissues.
RNase2 has been shown to be induced in response to LPS [64], the
intestinal pathogenic bacterium Clostridium diﬃcile, and the airway
epithelial microbe S. aureus [24,65]. RNase6 has been reported to be
induced in response to infection in the urinary tract in humans and
mice [33,34]. RNase7 is up-regulated in skin cells during infection with
various pathogenic microbes [25,31,32,59]. Together, these ﬁndings
suggest that these RNases may play an important role as eﬀector
proteins in a range of tissues.
Tissues that are exposed to the environment secrete a range of
antimicrobial proteins [66,67]. A number of host-defence related
proteins such as cathelicidins and defensins are known to be up-
regulated in response to infection in some tissues, including the small
intestine [68,69]. Since RNases are known to withstand high tempera-
ture and low pH and are reported to be resistant to some proteases
[70,71], it is conceivable that at least some of the RNase4 and RNase5
present in colostrum and milk could remain intact after ingestion and
be present in an active form in the intestine where they may contribute
to optimising the commensal microbial population of the newborn.
Veriﬁcation of this idea awaits further investigation.
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